Articles published by Belite Bio, Inc
Belite Bio Announces $25 Million Registered Direct Offering
April 25, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
March 22, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 11, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 11, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
March 06, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 30, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the BTIG Ophthalmology Day
November 20, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
November 13, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
November 07, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
October 27, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
August 04, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
July 27, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
May 10, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
March 31, 2023
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio Finalizes Phase 3 Clinical Trial Plans for Advanced Dry AMD Treatment with Tinlarebant (LBS-008)
November 18, 2022
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
October 20, 2022
From Belite Bio, Inc
Via GlobeNewswire
Tickers
BLTE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.